Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Applied Research Systems Ars Holding N.V.
Antonio Guarna
Mario Serio
Laboratoires Serono S.A.
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT96FI000019Aexternal-prioritypatent/IT1286545B1/en
Application filed by Applied Research Systems Ars Holding N.V., Antonio Guarna, Mario Serio, Laboratoires Serono S.A., Merck Serono SafiledCriticalApplied Research Systems Ars Holding N.V.
Publication of CA2245758A1publicationCriticalpatent/CA2245758A1/en
Application grantedgrantedCritical
Publication of CA2245758CpublicationCriticalpatent/CA2245758C/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention refers to benzo[c]quinolizine derivatives of general formula (I), their pharmaceutically acceptable salts or esters, processes for their preparation and pharmaceutical compositions containing them.
CA 22457581996-02-091997-02-07Benzo[c]quinolizine derivatives, their preparation and use as 5.alpha.-reductases inhibitors
Expired - Fee RelatedCA2245758C
(en)
Quinoline derivatives as type iv phosphodiesterase inhibitors, process for their preparation, pharmaceutical compositions containing the same and their use
Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them